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Lung differentiationption factor found exclusively in epithelial cells, is expressed in the distal lung
epithelium during embryogenesis, then becomes restricted to proximal airways at the end of gestation and
postnatally. To test the hypothesis that ELF5 represses distal epithelial differentiation, we generated a
transgenic mouse model in which a doxycycline inducible HA-tagged mouse Elf5 transgene was placed under
the control of the lung epithelium-speciﬁc human SFTPC promoter. We found that expressing high levels of
ELF5 during early lung development disrupted branching morphogenesis and produced a dilated epithelium.
The effects of ELF5 on morphogenesis were stage-dependent, since inducing the transgene on E16.5 had no
effect on branching. ELF5 reduced expression of the distal lung epithelial differentiation markers Erm, Napsa
and Sftpc, and type II cell ultrastructural differentiation was immature. ELF5 overexpression did not induce
the proximal airway epithelial markers Ccsp and Foxj1, but did induce expression of p63, a marker of basal
cells in the trachea and esophagus. High ELF5 levels also induced the expression of genes found in other
endodermal epithelia but not normally associated with the lung. These results suggest that precise levels of
ELF5 regulate the speciﬁcation and differentiation of epithelial cells in the lung.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe mouse lung ﬁrst appears at E9.5 as two outgrowths from the
foregut endoderm that invade the adjacent splanchnic mesoderm.
Following this initial event, the foregut endoderm undergoes stereo-
typic branching within the lung mesenchyme to form the basic
structure of the pulmonary tree. Later in gestation and in early
postnatal life, the lung goes through stages of distal airway expansion,
distal and proximal airway cellular differentiation, septation and
alveolarization. These events are all dependent on the correct
spatiotemporal expression and regulation of genes and proteins
such as transcription factors and secreted factors (Cardoso and Lu,
2006; Maeda et al., 2007; Warburton et al., 2005).
Secreted factors are known to be responsible for intercellular
interactions that occur between the lung epithelium andmesenchyme
(Shannon and Hyatt, 2004). For example, FGF10 secreted by the lung
mesenchyme signals through FGFR2b in the epithelium and acts as a
chemoattractant on the epithelium to drive branching morphogenesis
(Bellusci et al., 1997; Hyatt et al., 2004; Min et al., 1998; Ohuchi et al.,
2000; Park et al., 1998; Sekine et al., 1999) and to maintain al rights reserved.
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non).population of progenitors that later differentiate into the peripheral
cell types of the lung (Hokuto et al., 2003; Perl et al., 2002b;
Ramasamy et al., 2007). Other factors also inﬂuence the branching
epithelium, notably BMPs and Wnts, which are important for distal/
proximal speciﬁcation of the epithelium as well as maintenance of
lung epithelial progenitors (Bellusci et al., 1996; Dean et al., 2005;
Elblaghie et al., 2006; Hyatt et al., 2002; Hyatt et al., 2004;Mucenski et
al., 2003; Okubo and Hogan, 2004; Shu et al., 2005; Weaver et al.,
2000; Weaver et al., 1999).
Secreted ligands such as FGF10 bind their receptors and initiate
signaling cascades that activate downstream target genes. In a
previous study we identiﬁed Elf5 (Ese2) as a gene activated in the
embryonic lung epithelium by FGF signaling (Metzger et al., 2007).
ELF5 is a member of the Ese (Epithelial Speciﬁc Ets) family that was
originally reported as being expressed in differentiating keratinocytes
and branching epithelia such as salivary gland, prostate, mammary
gland and kidney (Oettgen et al., 1999; Zhou et al., 1998). We found
that Elf5 expression was dynamic throughout lung development.
During early branching morphogenesis Elf5 expression was restricted
to the distal lung epithelium, then became enriched in the proximal
airway epithelium and diminished distally at the end of gestation and
into postnatal lung development. From these results we hypothesized
that ELF5 may initially act to regulate epithelial branching, then later
in development increased ELF5 in the proximal epithelium may
negatively regulate distal epithelial gene expression and differentia-
tion. To test these hypotheses, we have now performed gain-of-
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the control of the lung epithelium-speciﬁc human SFTPC promoter.
We found that ELF5 misexpression disrupts branching morphogenesis
and negatively regulates distal lung epithelial differentiation. Micro-
array analysis of lungs overexpressing ELF5 reveals the repression of
some type II cell-speciﬁc genes, but the induction of others. High
levels of ELF5 expression also induced the expression of genes not
typically found in the distal lung epithelium, suggesting that ELF5 can
inﬂuence eventual cell fate.
Materials and methods
Generation of HA-Elf5 mice
The full-length mouse Elf5 cDNA was ampliﬁed from E12.5 lung by RT-PCR using
primers 5′-CGGGATCCCGATGGCGTACCCATACGACGTGCCTGACTACGCCTCCCTCATGTTG-
GAACTCCGTA-3′ and 5′-CCATCGATGGCCATCAAATGAGCCTGGTGT-3′ to add an N-
terminal HA-tag to the ELF5 protein and 5′ BamHI and 3′ ClaI cut sites to facilitate
cloning. The PCR product was then ligated into the rtTA inducible pTRE-Tight vector
(Clontech, Mountain View, CA) digested with BamHI and ClaI. The pTRE-Tight-HA-Elf5
vector was cut with XhoI to give a fragment that was used for injection into FVB/N
oocytes by the Cincinnati Children's Hospital Research Transgenic Core Facility.
Genotyping was performed by PCR on genomic DNA using 2 different primer sets.
The ﬁrst primer set, 5′-CGTATGTCGAGGTAGGCGTGTA-3′ and 5′-TCAGGTTCAGGGG-
GAGGTGTG-3′, was speciﬁc for the pTRE-Tight promoter while the second primer set,
5′-TACCCATACGACGTGCCTGAC-3′ and 5′-CCATCGATGGCCATCAAATGAGCCTGGTGT-3′
was speciﬁc for the HA-Elf5 transgene.
Conditional expression of the HA-Elf5 transgene to lung epithelium was
accomplished by breeding SFTPC-rtTA mice (Perl et al., 2002a) to HA-Elf5 mice
(hereafter SFTPC/Elf5 mice) and then treating the mice with doxycycline (Dox). Except
as noted below, pregnant dams were treated with Dox from the day of conception.
Transgene expression was traced using anti-HA immunohistochemistry (IHC).
Littermates bearing a single transgene (SFTPC-rtTA or HA-Elf5) were used as controls.
Immunohistochemistry
Tissues were ﬁxed in 4% paraformaldehyde or formalin, embedded in parafﬁn, and
5 μm sections were cut for IHC. Primary antibodies used were: HA (rabbit, 1:200, Santa
Cruz Biotech; Santa Cruz, CA), mouse IgG1 (1:200, Cell Signaling; Danvers, MA), ELF5
(goat, 1:50, Santa Cruz Biotech), phosphohistone H3 (pHH3; mouse, 1:500, Santa Cruz
Biotech), Cleaved Caspase3 (rabbit, 1:5000; R & D; Minneapolis, MN), p63 (mouse 4A4,
1:50, Santa Cruz Biotech), Pro-SP-C (rabbit,1:1000 and guinea pig,1:1000), TTF1 (rabbit,
1:500), FoxA1 (guinea pig, 1:1000), FoxA2 (rabbit, 1:1000), CCSP (rabbit, 1:1000), FoxJ1
(rabbit, 1:5000). The antibodies against Pro-SP-C, TTF1, FoxA1, FoxA2, CCSP and FoxJ1
were generous gifts from Dr. JeffreyWhitsett. Double IHC staining was performed using
the ELF5 antibody with the rabbit Pro-SP-C antibody, or using the HA antibody with the
guinea pig Pro-SP-C antibody. Biotinylated secondary antibodies were used with the
ABC Vectastain kit (Vector Laboratories; Burlingame, CA). DAB with nickel enhance-
ment and the AEC peroxidase substrate kit (Vector Laboratories) were used for
visualization.
Proliferation analysis
The percentages of pHH3 positive epithelial and mesenchymal cells in E16.5 SFTPC-
rtTA and SFTPC/Elf5 lungs were counted after pHH3 staining. Speciﬁcally, three 20×
micrographs of representative ﬁelds were taken from three different control or double
transgenic lungs, and pHH3 positive and negative cells were counted. A minimum of
1000 epithelial cells and mesenchymal cells were counted per slide. Proliferation data
were statistically analyzed using a Student's t-test on GraphPad Prizm version 4.0
(GraphPad Software, San Diego, CA).
Microarray analysis
Cysts from the lungs of E16.5 SFTPC/Elf5 fetuses and spatially similar areas from
SFTPC-rtTA control lungs were dissected, and RNA was isolated using an RNeasy
Micro Kit (Qiagen, Valencia, CA). RNA from three SFTPC/Elf5 lungs and three SFTPC-rtTA
littermate lungs were used in the analysis. The microarray analysis was performed as
previously described (Metzger et al., 2007). Differentially expressed genes between
experimental and control samples were determined by performing a Student's t-test
(p≤0.05) and ﬁltering for genes that increased or decreased at least 2-fold. Differentially
expressed genes were further compared to genes from a previously published
microarray (Matsuzaki et al., 2006) using genes with two present calls in wild-type
adult type II cells.
RT-PCR and quantitative PCR
Adult alveolar type II cells were isolated by dispase digestion and differential
adherence (Rice et al., 2002) and MLE15 cells, which are immortalized distal epithelialcells, were grown in HITES medium (Wikenheiser et al., 1993). RNA for RT-PCR was
isolated and reverse transcribed into cDNA by standard methods. The primers used for
RT-PCR were as follows:
Elf5, forward: 5′-GGACTCCGTAACCCATAGCA-3′
reverse: 5′-TACTGGTCGCAGCAGAATTG-3′;
Sftpc, forward: 5′-CATACTGAGATGGTCCTTGAG-3′
reverse: 5′-TCTGGAGCCATCTTCATGATG-3′
β-actin, forward: 5′-TGGAATCCTGTGGCATCCATGAAAC-3′
reverse: 5′-TAAAACGCAGCTCAGTAACAGTCCG-3′
For quantitative PCR (qPCR), we dissected cysts from E16.5 SFTPC/Elf5 lungs
treated with doxycycline from E0–E16.5, isolated the RNA, and generated cDNA.
Spatially similar areas from non-transgenic or single transgenic SFTPC-rtTA or HA-Elf5
littermate lungs served as controls. Analysis was done on 3–5 independent tissue
isolations. We performed qPCR using Taqman probe and primer sets (Applied
BioSystems, Foster City, CA) speciﬁc for Elf5 (Assay ID: Mm00479832_m1), Ese3/Ehf
(Mm00468193_m1), Spdef (Mm00600221_m1), Ese1/Elf3 (Mm00468224_m1), Sftpc
(Mm00488144_m1), Erm/Etv5 (Mm00465816_m1), Pea3/Etv4 (Mm01245872_m1),
Spink5 (Mm00511522_m1), Spink4 (Mm00803437_m1), Scgb3a1 (Mm00446493_m1),
Scgb3a2 (Mm00504412_m1), TFF3 (Mm00495590_m1) and p63/ Trp63
(Mm00495788_m1), and Napsa (Mm00492829_m1). A probe and primer set for
18s rRNA was used as the normalization standard. The PCR reactions and relative
quantiﬁcations were performed using 25 ng of cDNA per reaction in a 7300 Real-
Time PCR Sytem (Applied BioSystems). Relative quantiﬁcation data from qPCR
analysis were statistically analyzed using Student's t-tests on GraphPad Prizm
version 4.0.Results
Expression of ELF5 during lung development
We previously reported that Elf5mRNA is initially expressed in the
distal tip lung epithelium at E11.5, becomes highly expressed in the
proximal airway epithelium as development progresses, then
decreases distally (Metzger et al., 2007). We have now extended
these observations to determine expression of ELF5 protein in lungs by
IHC and found an identical pattern throughout gestation. ELF5 was
localized to the nuclei of epithelial cells in the branching distal tips,
but absent from the proximal epithelium at E14.5 (Fig. 1A). At E15.5
ELF5 was expressed in the proximal epithelium as well as the distal
epithelium (Fig. 1B), and there was a low level of the distal epithelial
marker Pro-SP-C expressed in the distal tips (Fig. 1C). E16.5 lungs
showed increased ELF5 expression in the proximal airway epithelium
and continued ELF5 expression in the distal epithelium (Fig. 1D), while
Pro-SP-C, a marker speciﬁc to distal lung epithelium in the fetus and to
alveolar type II cells postnatally, was still expressed at a relatively low
level (Fig. 1E). At E17.5, cells of the airway epithelium showed strong
staining for ELF5 compared to cells in the lung parenchyma (Figs.1G,I),
and Pro-SP-C was strongly expressed in presumptive alveolar type II
cells (Fig. 1H). To determine the identity of the ELF5 positive cells in
the lung parenchyma at E17.5, we performed double IHC for ELF5 and
Pro-SP-C and found that ELF5 positive cells in the lung parenchyma
were presumptive type II cells (Fig. 1K). Because alveolarization
continues after birth, we further evaluated the co-expression of
ELF5 and Pro-SP-C protein in the lungs of postnatal day 6 (PND6) and
4-week old mice (Figs. 1L,M). ELF5 was undetectable in Pro-SP-C
positive type II cells at these time points, which is consistent with our
previous ISH results (Metzger et al., 2007), and a previous study that
used a different ELF5 antibody (Lapinskas et al., 2004). We observed
some apical staining with the ELF5 antibody, but determined that this
was non-speciﬁc (Fig. 1J). Because the IHC data showed that distal
expression of Elf5 decreased as Sftpc increased, we performed RT-PCR
for Elf5 and Sftpc on isolated adult type II cells and on the
immortalized distal epithelial cell line MLE15. The results (Fig. 1F)
revealed an inverse relationship between Elf5 and Sftpc expression.
Although the RT-PCR data indicate that Elf5 is present at low levels in
adult type II cell preparations, this may be due to the fact that isolated
type II cell preparations typically contain some contaminating
proximal epithelial cells. Overall the data indicate that Elf5 expression
is very low in fully differentiated distal epithelial cells.
Fig.1. Endogenous expression of ELF5 and Pro-SP-C protein expression during lung development. ELF5 is expressed at the tips of branching lung epithelium (arrows) at E14.5 (A). ELF5
expression continues in branching epithelium (arrows) at E15.5 but is also expressed in the developing airway epithelium (arrowhead) (B). Pro-SP-C is expressed in tips of branching
epithelium (arrow) but is not expressed in the proximal airway (arrowheads) (C). ELF5 is present in the airways (arrowheads) and in lung parenchymal cells (arrows) at E16.5 and
E17.5 (D, G), while Pro-SP-C is found exclusively in cells in the distal lung parenchyma (arrows) and not the airway (arrowhead) (E,H). ELF5 is seen in many cells in the E17.5 airway
(arrowhead) and parenchyma (arrow) (I). Staining on the apical surfaces of some luminal cells is non-speciﬁc as determined by the ELF5 peptide block control (J). Double IHC staining
of E17.5 lungs for ELF5 and Pro-SP-C indicates that distal cells expressing ELF5 also stain for Pro-SP-C (K), whereas ELF5 is undetectable in Pro-SP-C positive type II cells in postnatal
day 6 (PND6) (L) and 4 week lungs (M). RT-PCR shows an inverse relationship between Elf5 expression and Sftpc expression in MLE15 cells and in isolated type II cells (F). Scale bars:
100 μm in A–E, G, H; 50 μm in I, J and 20 μm in K–M.
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morphogenesis
Our previous study (Metzger et al., 2007) indicated that the distal
epithelial expression of Elf5 during the pseudoglandular stage of lung
development was regulated by FGF signaling and was speciﬁcally
downstream of FGFR2b. We hypothesized that ELF5 might play a
downstream role in FGF signaling that is important for lung
morphogenesis and differentiation. In order to investigate the
function of ELF5 during branching morphogenesis and its role in
distal epithelial differentiation, we used the 3.7 kb human SFTPC
promoter to direct expression of a Dox-inducible HA-Elf5 transgene to
the distal lung epithelium (SFTPC/Elf5mice). Recently, a longer isoform
of ELF5 has been described that contains an additional 31 amino acidsat the N-terminus (Choi and Sinha, 2006); these isoforms were
designated as ESE2 and ESE2L (with the additional 31 amino acids).
Our misexpressed ELF5 protein corresponds to the ESE2 isoform.
We identiﬁed a transgenic line in which Elf5 was expressed at a
high level; at E16.5 the lungs of these mice showed a 16-fold increase
over endogenous Elf5 expression (Fig. 8). When we examined the
effects of increased ELF5 expression on E14.5 we found that, compared
to the typical ﬁne branches in lungs of single transgenic littermate
control animals (Fig. 2A), the lungs from double transgenic embryos
that were treated with Dox from conception had dilated distal
branches (Fig. 2B). This phenotype was not uniform throughout the
lungs of double transgenic embryos, because branching appeared
normal in some areas. When we traced expression of the HA-ELF5
fusion protein using HA IHC, we found that the HA-Elf5 transgene was
Fig. 2. Misexpression of ELF5 in distal lung epithelial cells disrupts branching
morphogenesis at E14.5. Control lungs from an E14.5 SFTPC-rtTA embryo show typical
ﬁne branches (A), whereas the lungs from an E14.5 SFTPC/Elf5 embryo display areas of
epithelial dilation (B). Note that in this preparation only one lobe appears to be affected
(⁎). A left lung from a control E16.5 SFTPC-rtTA embryo, showing ﬁnely branched distal
tips (C). The left lung from an E16.5 SFTPC/Elf5 embryo (D) showing widespread dilated
epithelium, which are readily apparent at higher magniﬁcation (E, F). Histology of E16.5
SFTPC-rtTA (G) and SFTPC/Elf5 (H) lungs demonstrates that the dilated epithelium is
widespread, although some areas appear unaffected. Immunostaining for HA in SFTPC/
Elf5 lungs on E14.5 (I) and E16.5 (J) shows those cells expressing the HA-Elf5 transgene
(arrows). Note that not all of the epithelial cells stain positive. Scale bars: 500 μm in A–D,
G, H; 200 μm in E, F, I, J.
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appeared to be mosaic, which likely contributed to the variability in
phenotype. Lungs from E16.5 embryos treated with Dox from
conception gave similar phenotypes (Figs. 2C–F), with the distal
epithelium in SFTPC/Elf5 lungs displaying dilated, cystic branches
(Figs. 2D,F,H) compared to the ﬁne branches of single transgenic
controls (Figs. 2C,E,G).We conﬁrmed expression of the HA-ELF5 fusion
protein in the E16.5 SFTPC/Elf5 lung epithelium by IHC (Fig. 2J) and
again observed mosaic expression.
High ELF5 expression inhibits epithelial proliferation
Proper branching morphogenesis requires a high rate of cellular
proliferation to generate the number of cells required for tissue
expansion, and a cystic phenotype may result in the absence ofsufﬁcient proliferation. One possible reason for the inhibition of
branching we observed in SFTPC/Elf5 lungs is that proliferation was
decreased. We therefore assessed the rate of proliferation in lungs
from E16.5 SFTPC/Elf5 and control mice by IHC for pHH3, a marker for
dividing cells (Figs. 3A,B). Epithelial cells in the periphery of single
transgenic control lungs stained strongly for pHH3 (Fig. 3A), indicating
a high rate of proliferation. We observed much lower epithelial pHH3
staining in the lungs of SFTPC/Elf5 fetuses (Fig. 3B). Quantiﬁcation of
the percentage of proliferating epithelial cells revealed a signiﬁcant
decrease of epithelial proliferation in double transgenic lungs (Fig. 3C).
There was no signiﬁcant change in mesenchymal proliferation
between control and experimental lungs (Fig. 3D), demonstrating
that the effect of high ELF5 expression on proliferation was speciﬁc to
the epithelium. To determine if the HA-ELF5 fusion protein was
inducing cell death in double transgenic lungs, we stained for the
apoptosis marker cleaved caspase 3. We saw very few apoptotic cells
in either control (Fig. 3E) or double transgenic lungs, even in areas of
high transgene expression (Fig. 3F').
High ELF5 expression inhibits distal epithelial differentiation
The results in Fig. 1 demonstrate that although distal epithelial
expression of ELF5 is high during branching morphogenesis, it is
extinguished postnatally. In contrast, proximal epithelial ELF5
expression is low early in gestation, but progressively increases in
late gestation and after birth. One possible explanation for this
dynamic expression pattern is that ELF5 plays a role in suppressing
distal differentiation. To determine the effects of ELF5 overexpression
on distal epithelium differentiation, we evaluated the lungs of E16.5
embryos that had been exposed to Dox since conception for markers
of lung epithelial differentiation (Fig. 4). As expected, we found that
Pro-SP-C protein was uniformly expressed in distal epithelial cells in
control lungs (Fig. 4A). We did not detect Pro-SP-C expression in the
dilated cysts of SFTPC/Elf5 lungs, although histologically normal lung
tissue in the same section expressed the protein (Fig. 4B). We also
assessed the expression of other proteins known to be important in
distal lung epithelial differentiation. We found that virtually all of the
epithelial cells in SFTPC/Elf5 lungs were positive for FOXA1 (Figs. 4E,F)
and FOXA2 (Figs. 4G,H), which are markers of endoderm. Similarly, all
of the epithelial cells stained positive for TTF1 (Figs. 4C,D), indicating
that the cells had entered the respiratory lineage.
We next examined lungs at E18.5, when saccule development has
begun in the normal lung (Fig. 5A). We found the same morphology
of dilated epithelial cysts in SFTPC/Elf5 lungs (Fig. 5B). The dilated
cysts persisted in the lungs of adults (Fig. 5D), whereas controls were
extensively alveolarized (Fig. 5C). Similar to lungs from E14.5 and
E16.5 embryos, the extent of phenotype was variable, with some
lobes in adult lungs apparently unaffected (data not shown). Because
Pro-SP-C was undetectable in the cysts of E18.5 SFTPC/Elf5 lungs, we
examined these regions by electron microscopy for evidence of
changes in type II cell ultrastructural differentiation. We found that
SFTPC-rtTA control lungs contained many glycogen-laden type II
cells with microvilli and cytoplasmic lamellar bodies, which are the
storage organelle for pulmonary surfactant. Secreted surfactant was
present in the alveolar lumina (Fig. 5E). In contrast, the epithelial
cells forming the dilated cysts of SFTPC/Elf5 E18.5 lungs were
undifferentiated. Low cuboidal epithelial cells contained copious
glycogen deposits, but did not contain lamellar bodies. Secreted
surfactant was never seen in luminal spaces of cystic regions. The
interstitial space adjacent to the epithelial lining was very loosely
organized, and the resident ﬁbroblasts contained many lipid droplets
(Fig. 5F).
Pro-SP-C immunostaining on lungs from fetuses continuously
exposed to Dox through day E18.5 (DOX E0–E18.5), gave results
similar to those observed on E16.5: Pro-SP-C expression was
undetectable in the dilated cysts of SFTPC/Elf5 lungs, whereas control
Fig. 3. ELF5 overexpression inhibits epithelial proliferation. IHC for the proliferation marker phospho-Histone H3 (pHH3) in E16.5 SFTPC-rtTA (A) and SFTPC/Elf5 (B) lungs shows
decreased epithelial staining in SFTPC/Elf5 lungs. Quantiﬁcation of the percentage of epithelial cells and mesenchymal cells staining for pHH3 in SFTPC/Elf5 lungs compared to SFTPC-
rtTA lungs shows that epithelial proliferation (C) was signiﬁcantly decreased in SFTPC/Elf5 lungs (pb0.05), whereas mesenchymal proliferation (D) did not change. IHC for the
apoptosis marker cleaved caspase 3 shows that few positive cells are found in either SFTPC-rtTA control lungs (E) or SFTPC/Elf5 lungs (F). A consecutive section to that shown in F
stained for HA shows HA-ELF5 is expressed in the area of the epithelium evaluated for cleaved caspase 3 (F'). Scale bar: 100 μm.
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lungs strongly expressed the protein (Figs. 6A,B). Accordingly, HA IHC
of these lungs revealed that the HA-Elf5 transgene expression was
only seen in the epithelium of dilated cysts and was absent from
unaffected areas (Fig. 6K).
In order to determine if the effects of Elf5 overexpression were
dependent on the developmental stage at which the transgene was
induced, we waited until E16.5 to treat dams with Dox (DOX E16.5–
E18.5). This delayed induction of the HA-Elf5 transgene until the end
of the pseudoglandular stage, when patterning of the pulmonary tree
has been completed, but formation of acini and saccules is still
ongoing. We found that the morphology of DOX E16.5–E18.5 embryos
was very similar lung morphology to control littermates. We did not
observe cystic dilation of the distal epithelium, even when transgene
expression was widespread (Fig. 6L). However, we still observed
decreased Pro-SP-C expression in SFTPC/Elf5 lungs (Fig. 6H) compared
to those of single transgene littermate controls (Fig. 6G). Double IHC
staining revealed that HA positive cells did not co-express Pro-SP-C
(Figs. 6I,J), conﬁrming that high ELF5 levels in late gestation still
repressed Pro-SP-C expression.Since ELF5 is highly expressed in the airway epithelium in late
gestation we speculated that ELF5 might induce genes speciﬁc to the
proximal airway epithelial cell differentiation. We therefore evaluated
CCSP, a marker of Clara cells, in DOX E0–E18.5 lungs by IHC. We found
that endogenous CCSP was present in the proximal airway epithelium
of both DOX E0–E18.5 and control lungs (Figs. 6C,D). Notably, the distal
cystic epithelium of SFTPC/Elf5 lungs was negative for CCSP (Figs. 6D).
In parallel with these results, expression of the ciliated cell marker,
FOXJ1, was restricted to the proximal airway epithelium in both
control and experimental lungs, and was not seen in the cystic
epithelium (Figs. 6E,F).
Microarray analysis
The lack of Pro-SP-C expression and the appearance of immature
cuboidal epithelial cells in double transgenic lungs suggested that
distal epithelial cell differentiation was impaired; however, the fate
of the cells in the cysts was unknown. To gain some insight into the
identity of the cells, we isolated cystic regions of E16.5 SFTPC/Elf5
lungs and spatially similar regions from the lungs of SFTPC-rtTA
Fig. 5. Histology of E18.5 SFTPC-rtTA (A) and SFTPC/Elf5 (B) lungs shows that expression
of ELF5 transgene disrupts acinar formation, and this persists in adult control (C) and
double transgenic (D). Electron micrographs of E18.5 SFTPC-rtTA control (E) and SFTPC/
Elf5 (F) lungs reveal ultrastructural differences. SFTPC-rtTA lungs (E) contain normal
type II cells that exhibit apical microvilli (⁎) and cytoplasmic lamellar bodies
(arrowhead); surfactant is seen in the alveolar lumen (arrows). In contrast, the cystic
epithelium of SFTPC/Elf5 lungs (F) is predominantly composed of immature cuboidal
cells lacking apical microvilli (arrowheads) and cytoplasmic lamellar bodies; secreted
surfactant could not be found in the cyst lumina. Fibroblasts in the loosely-organized
interstitium adjacent to the cystic epithelium contain many lipid droplets (⁎). Scale
bars: 200 μm in A, B; 500 μm in C, D.
Fig. 4. Effects of ELF5 misexpression on gene expression in E16.5 lungs. Sections of
SFTPC-rtTA control lungs (A) and SFTPC/Elf5 lungs (B) stained for Pro-SP-C protein
show that it is not detectable in the cystic epithelium of SFTPC/Elf5 lungs (asterisks),
although histologically normal regions still express the protein (B; arrow). Control lungs
stain uniformly for Pro-SP-C (A). IHC for TTF1 shows strong expression in the epithelium
of both control (C) and SFTPC/Elf5 (D) lungs. IHC for FOXA1 (E, F) and FOXA2 (G, H)
shows no differences in staining for either protein in SFTPC/Elf5 lungs compared to
SFTPC-rtTA controls. Scale bar: 100 μm.
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ELF5 and other ESE transcription factors have not been well
characterized (Choi and Sinha, 2006), we hypothesized that micro-
array analysis would provide candidate ELF5 target genes. We found
that overexpression of ELF5 activated 202 genes at least 2-fold and
decreased the expression of 123 genes. These included genes
involved in transcriptional regulation, transport, receptor activity,
intracellular signaling, adhesion, and a number of secreted proteins
(Supplement).
Since differentiation of type II cells in E18.5 SFTPC/Elf5 lungs was
defective, we compared the list of differentially expressed genes to
those present in isolated wild-type adult mouse type II cells; 40 of the
123 genes that decreased with ELF5 overexpression were present in
differentiated type II cells (Table 1). Some of these genes are associatedwith type II cell differentiation. Both Erm (Etv5) and Napsa, which are
expressed in differentiated type II cells, were decreased in the
microarray, a result we conﬁrmed by qPCR (Fig. 8). Conversely, 92 of
202 genes that increased with ELF5 overexpression were present in
isolated type II cells (Table 2). Some of these genes, such as Sftpd,
Spink5, and Scgb3a1, are not only present in type II cells but are also
expressed in the proximal airway epithelium. The increases in Spink5
and Scgb3a1 were conﬁrmed by qPCR (Fig. 7A).
ELF5 also induced the expression of genes not typically associated
with the distal lung, such as Spink4, Guca2a, Tff3 and Dcpp
(Supplement); we veriﬁed the induction of Spink4 and Tff3 by qPCR
(Fig. 7A). We identiﬁed other genes increased in SFTPC/Elf5 lungs that
are not present in type II cells but are expressed in the proximal
airway epithelium (Supplement), such as Scgb3a2 (Reynolds et al.,
2002), whose upregulation in SFTPC/Elf5 lungs was veriﬁed by qPCR
(Fig. 7A). ELF5 overexpression also induced the expression of the basal
cell marker, p63, which is normally found in the pseudostratiﬁed
epithelium of the trachea and bronchus (Fig. 7H) as well as the
stratiﬁed esophageal epithelium. Becausewe observed Elf5 expression
Fig. 6. ELF5 represses SP-C expression in E18.5 lungs. IHC for Pro-SP-C in the lungs of SFTPC/Elf5 embryos that had been exposed to Dox since conception (DOX E0–E18.5)
reveals a lack of Pro-SP-C in the epithelial cysts (⁎) (B), whereas SFTPC-rtTA control lungs show widespread expression Pro-SP-C (A). IHC for CCSP shows endogenous
protein expression in the airway epithelium (arrows) of both control (C) and SFTPC/Elf5 lungs (D). Note the lack of CCSP induction in the epithelium of the cysts (⁎) of
double transgenic lungs (D). Similarly, IHC for FOXJ1 in control (E) and SFTPC/Elf5 lungs (F) shows endogenous protein expression in the airway epithelium, but no
induction in the cystic epithelium (⁎) of SFTPC/Elf5 lungs (F). IHC for Pro-SP-C in the lungs of embryos that had been exposed to Dox from E16.5 to E18.5 (DOX E16.5–
E18.5) shows a decided decrease in Pro-SP-C positive cells in SFTPC/Elf5 lungs (H) compared to SFTPC-rtTA controls (G). Double IHC of HA and Pro-SP-C in DOX E16.5–E18.5
SFTPC/Elf5 lungs (I, J) shows that Pro-SP-C is repressed in cells that stain positive for the HA-Elf5 transgene. IHC for HA in DOX E0–E18.5 SFTPC/Elf5 lungs shows that the
transgene is expressed in the cystic epithelium, but is not found in histologically normal areas (K). In contrast, transgene expression is widespread in DOX E16.5–E18.5
SFTPC/Elf5 lungs (L), but overall histology is normal (compare H and L to A) indicating that the effects of ELF5 misexpression on morphogenesis occur prior to E16.5. Scale
bars: 100 μm in A–I, K, L; 20 μm in J.
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DOX E0–E16.5 SFTPC/Elf5 lungs by IHC. We found that p63 was
detectable in the cysts of double transgenic lungs (Fig. 7C), while
control lungs lacked p63 expression in the distal epithelium (Fig. 7B).
Similarly, p63 was also induced in DOX E16.5–E18.5 double transgenic
E18.5 lungs (Fig. 7E), but not in controls (Fig. 7D). Esophageal
epithelium, previously reported to have a high expression of p63
(Daniely et al., 2004; Que et al., 2007), was used as an internal positive
control for experimental samples (Figs. 7B,D, insets).
ELF5 regulates the expression of other Ets factors in the lung
Along with the predicted increase of Elf5, another Epithelial
Speciﬁc Ets factor, Ese3, was increased in the microarray and was
also present in type II cells (Table 2); these data were conﬁrmed with
qPCR (Fig. 8). We then evaluated by qPCR the expression of other
Epithelial Speciﬁc Ets factors, Spdef and Ese1, which were not changed
as determined by microarray. We found that Spdef, previously
described as a marker for goblet cells in the airway epithelium (Park
et al., 2007), was signiﬁcantly increased in SFTPC/Elf5 lungs, but Ese1
expression did not change (Fig. 8). Erm, which has previously beenshown to be highly expressed in type II cells, to directly activate the
Sftpc promoter, and to be critical for distal epithelium differentiation
(Lin et al., 2006; Liu et al., 2003) was decreased in bothmicroarray and
qPCR analyses. We also found that Sftpc expression was reduced by
microarray and qPCR (Fig. 8), supporting our IHC results (Fig. 6). Pea3,
which is thought to play a redundant role to Erm (Liu et al., 2003), did
not change (Fig. 8).
Discussion
ELF5 expression during lung development
We previously reported that Elf5 is expressed in the distal tip lung
epithelium at E11.5, becomes more highly expressed in the proximal
airway epithelium as development progresses, then decreases distally
at the end of gestation and postnatally (Metzger et al., 2007). We have
now extended these observations to show that ELF5 protein expres-
sion follows a parallel pattern throughout gestation. As late as E17.5,
the distal epithelial cells that expressed ELF5 co-expressed Pro-SP-C,
identifying them as presumptive type II cells. ELF5 expression was no
longer detectable in Pro-SP-C positive type II cells after birth, which is
Table 1
Genes present in adult type II cells but decreased with Elf5 overexpression
Fold
decrease
Accession Abbreviation Name
14.45 AW215442 C130039A10
5.62 NM_019806 Vapb Vesicle-associated membrane
protein, associated protein B and C
5.56 XM_132070 Cyt1 Cytokine like 1
5.05 NM_008437 Napsa Napsin A aspartic peptidase
4.35 NM_026085 3110049J23Rik
3.85 NM_026055 Rpl39 Ribosomal protein L39
3.31 XM_620753 Zfp291 Zinc ﬁnger protein 291
3.15 NM_027041 1700003M02Rik
3.04 NM_001024617 Inpp4b Inositol polyphosphate-4-
phosphatase, type II
2.92 NM_007663 Cdh16 Cadherin 16
2.82 NM_010819 Clec4d C-type lectin domain family 4,
member d
2.79 XM_137239 Ppp1r12a Protein phosphatase 1, regulatory
(inhibitor) subunit 12A
2.68 NM_021475 Adamdec1 ADAM-like, decysin 1
2.67 NM_139144 Ogt O-linked N-acetylglucosamine
(GlcNAc) transferase
2.65 NM_011018 Sqstm1 Sequestosome 1
2.62 NM_011909 Usp18 Ubiquitin speciﬁc protease 18
2.58 NM_010266 Gda Guanine deaminase
2.58 NM_013835 Ssa2 Sjogren syndrome antigen A2
2.38 NM_031374 Tex15 Testis expressed gene 15
2.36 NM_021344 Tesc Tescalcin
2.35 NM_019394 Mia1 Melanoma inhibitory activity 1
2.34 NM_007780 Csf2rb1 Colony stimulating factor 2
receptor, beta 1, low-afﬁnity
2.34 AK028312 3526402J09Rik
2.31 NM_145374 BC020002
2.31 NM_007499 Atm Ataxia telangiectasia mutated gene
2.30 NM_013514 Epb4.9 Erythrocyte protein band 4.9
2.28 NM_009105 Rsu1 Ras suppressor protein 1
2.28 NM_010448 Hnrpab Heterogeneous nuclear
ribonucleoprotein A/B
2.25 XM_135030 Ibtk Inhibitor of Bruton
agammaglobulinemia tyrosine
kinase, transcript variant 1
2.24 NM_011378 Sin3a
2.23 NM_030143 Ddit4l DNA-damage-inducible transcript
4-like
2.17 BQ175321 2900022I03Rik
2.16 NM_010762 Mal Myelin and lymphocyte protein
2.16 NM_144820 1700009P13Rik
2.16 NM_011638 Tfrc Transferrin receptor
2.10 NM_013785 Ihpk1 Inositol hexaphosphate kinase 1
2.09 NM_023794 Etv5 Ets variant gene 5
2.07 NM_021559 Zfp191 Zinc ﬁnger protein 191
2.07 NM_019472 Myo10 Myosin X
2.03 NM_013825 Ly75 Lymphocyte antigen 75
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study using a different ELF5 antibody (Lapinskas et al., 2004). These
data indicate that Elf5 expression is very low in differentiated type II
cells, and suggested the possibility that ELF5 may play a role in
negatively regulating Sftpc. Although our microarray data (Table 2)
indicate that Elf5 is present in type II cell preparations, our RT-PCR
results indicate that the expression is at low levels. We believe that
this low level of expression is due to the fact that isolated type II cell
preparations typically contain some contaminating proximal epithe-
lial cells, which are Elf5 positive in the postnatal lung.
ELF5 overexpression causes lung branching defects
Our previous study indicated that the distal epithelial expression
of Elf5 during the pseudoglandular stage of lung development was
regulated by FGF signaling, and was speciﬁcally downstream of
FGFR2b. Because of the importance of FGF10, which uses FGFR2b as
its primary receptor, in lung development (Min et al., 1998; Sekineet al., 1999), we hypothesized that ELF5 might act downstream in
regulating morphogenesis and differentiation. We tested this hypoth-
esis by overexpressing ELF5 using the human SFTPC promoter, which
is active in the epithelium from the beginning of mouse lung
development (Perl et al., 2002b). We found that misexpressed ELF5
disrupted branchingmorphogenesis, as evidenced by the formation of
dilated cysts in the distal epithelium. This phenotype, which we
detected as early as E14.5, persisted throughout gestation and into
postnatal life. HA IHC veriﬁed that the transgene was being expressed
in the distal epithelium, but its expression was mosaic, causing a
partially cystic phenotype. We also observed that only a subset of cells
in the cystic regions were transgene positive as gauged by HA IHC. The
basis for this mosaic expression pattern is unknown. One possible
explanation stems from our observation that ELF5 decreases Sftpc
expression (Fig. 4): since we drove ELF5 expression using the SFTPC
promoter, it could have the secondary effect of reducing its own
expression, but only in a subset of cells. Alternatively, transgene
expression may have only been high enough to detect in a subset of
cells, and these affected their neighbors through crosstalk via secreted
factors. The effects of ELF5 overexpression on lung branching were
restricted to a window during development, however, because
morphogenesis was unaffected when the transgene was induced
beginning on E16.5, when basic patterning of the lung has been
mostly completed.
Cell proliferation not only sustains overall lung growth in the
embryo, but also inﬂuences lung patterning, since the rate of epithelial
proliferation is higher in branching regions (Weaver et al., 2000). One
possible result of insufﬁcient epithelial proliferation is decreased
branching and cyst formation. The phenotype we observed in SFTPC/
Elf5 embryos, where ELF5 speciﬁcally inhibited epithelial proliferation
in the cysts, is consistent with this concept. Analysis of a lung-speciﬁc
Elf5 knockout mouse model will be required to determine if ELF5
directly inhibits lung epithelial cell proliferation. The possibility that
ELF5 acts as a negative regulator of epithelial proliferation may be
tissue type-dependent, however, since mammary epithelial cell
proliferation decreases in mice heterozygous for a null Elf5 allele
(Zhou et al., 2005).
Increased ELF5 represses distal epithelial cell differentiation
Although distal epithelial expression of ELF5 is high during
branching morphogenesis, it is silenced postnatally. One possible
explanation for this dynamic expression pattern is that ELF5
negatively regulates distal differentiation. Our results showing that
overexpression of ELF5 in the distal epithelium causes decreased
expression of Sftpc and the loss of ultrastructural hallmarks of type II
cell differentiation are consistent with this possibility. In addition to
inhibiting Sftpc expression and type II cell differentiation, microarray
analysis revealed that 40 genes normally expressed in differentiated
adult type II cells were decreased in SFTPC/Elf5 lungs (Table 1). Two of
these genes, Erm (Etv5) and Napsa, have previously been shown to be
associated with differentiated type II cells (Brasch et al., 2003;
Chuman et al., 1999; Lin et al., 2006; Liu et al., 2003; Ueno et al.,
2004). ERM directly binds the Sftpc promoter to drive its transcription
(Lin et al., 2006). High ELF5 expressionmay therefore indirectly inhibit
Sftpc expression by reducing Erm expression. This may be occurring in
the normal adult airway epithelium, where ELF5 is highly expressed
and Erm is absent (Lin et al., 2006). It is also possible that ELF5 may
compete with ERM for Ets binding sites on the Sftpc promoter, which
would directly inhibit Sftpc transcription. The ETS domain of ELF5 can
function as a repressor (Choi and Sinha, 2006), suggesting the
possibility that ELF5 may directly inhibit Sftpc transcription. Reduced
levels of Napsa have also been associated with defective lung
epithelial differentiation in double heterozygous Gata6+/−-/Nkx2.1+/−
mutant embryos (Zhang et al., 2007). Notably, we found that the
effects of ELF5 misexpression on distal lung epithelial differentiation
Table 2
Genes present in adult type II cells and upregulated by Elf5 overexpression
Fold
Increase
Accession Abbreviation Name
255.9 XM_283487 Spink5 Serine protease inhibitor, Kazal type 5
120.3 NM_009789 S100g S100 calcium binding protein G
99.16 NM_010125 Elf5 E74-like factor 5
71.93 XM_619652 LOC545340 RIKEN cDNA 5031415C07 gene
69.17 NM_054037 Scgb3a1 Secretoglobin, family 3A, member 1
40.54 XM_129166 Mlana Melan-A
25.65 NM_010165 Eya2 Eyes absent 2 homolog (Drosophila)
17.84 NM_025786 Rnf186 Ring ﬁnger protein 186
12.79 NM_029639 1600029D21Rik
11.27 NM_175397 5830484A20Rik
10.8 NM_012031 Spag1 Sperm associated antigen 1
9.504 NM_011783 Agr2 Anterior gradient 2 (Xenopus laevis)
8.611 AK008789 2210401J11Rik
8.319 NM_009897 Ckmt1 Creatine kinase, mitochondrial 1,
ubiquitous
7.317 NM_172613 Atp13a4 ATPase type 13A4
6.361 NM_009132 Scin Scinderin
5.921 NM_183187 BC055107
5.862 NM_181579 Pof1b Premature ovarian failure 1B
5.534 NM_009897 Ckmt1 Creatine kinase, mitochondrial 1,
ubiquitous
5.291 BM933741
5.042 NM_011700 Vill Villin-like
4.803 NM_007914 Ehf Ets homologous factor
4.526 NM_028618 1110014F24Rik
4.119 NM_007995 Fcna Ficolin A
3.854 NM_146050 Oit1 Oncoprotein induced transcript 1
3.85 NM_008339 Cd79b CD79B antigen
3.797 NM_029639 1600029D21Rik
3.679 NM_007914 Ehf Ets homologous factor
3.609 NM_010330 Emb Embigin
3.526 NM_023270 Rnf128 Ring ﬁnger protein 128
3.492 NM_009402 Pglyrp1 Peptidoglycan recognition protein 1
3.411 NM_009700 Aqp4 Aquaporin 4
3.339 NM_133775 9230117N10Rik
3.326 NM_010330 Emb Embigin
3.259 NM_015761 Dos Downstream of Stk11
3.235 NM_008125 Gjb2 Gap junction membrane channel
protein beta 2
3.215 NM_009199 Slc1a1 Solute carrier family 1, member 1
3.188 NM_008528 Blnk B-cell linker
3.158 NM_146117 BC004853
3.124 NM_027286 Ace2 Angiotensin I converting enzyme 2
3.117 NM_177905 9230101H05Rik
3.046 XM_128291 Lypdc2 Ly6/Plaur domain containing 2
3.032 NM_001001179 BC048546
3.016 NM_018754 Sfn Stratiﬁn
3.01 AK014573 4632413I24Rik
2.998 NM_023270 Rnf128 Ring ﬁnger protein 128
2.964 NM_009434 Phlda2 Pleckstrin homology-like domain,
family A, member 2
2.961 NM_152823 Unc5cl Unc-5 homolog C-like
2.902 NM_008330 Iﬁ47 Interferon gamma inducible protein 47
2.874 NM_011315 Saa3 Serum amyloid A 3
2.802 BG175786 Transcribed locus
2.79 NM_011382 Six4 Sine oculis-related homeobox 4 homolog
2.675 NM_009199 Slc1a1 Solute carrier family 1, member 1
2.652 NM_145838 st8sia6 ST8 alpha-N-acetyl-neuraminide
alpha-2,8-sialyltransferase 6
2.635 NM_153404 Liph Lipase, member H
2.606 NM_134072 9030611N15Rik
2.603 NM_007494 Ass1 Argininosuccinate synthetase 1
2.601 NM_021297 Tlr4 Toll-like receptor 4
2.591 NM_019980 Litaf LPS-induced TN factor
2.563 NM_021451 Pmaip1 Phorbol-12-myristate-13-acetate-
induced protein 1
2.553 NM_133681 Tspan1 Tetraspan 1
2.496 NM_027096 2310032D16Rik
2.476 NM_011382 Six4 Sine oculis-related homeobox 4 homolog
2.407 NM_008118 Gif Gastric intrinsic factor
2.376 BI499978
2.364 NM_009763 Bst1 Bone marrow stromal cell antigen 1
2.332 NM_197945 Prosapip1 Proline-rich synapse-associated
protein-interacting protein 1
Table 2 (continued)
Fold
Increase
Accession Abbreviation Name
2.304 NM_008719 Npas2 Neuronal PAS domain protein 2
2.29 NM_033612 Ela1 Elastase 1, pancreatic
2.288 NM_029007 AW125753
2.252 NM_178715 Tmem30b Transmembrane protein 30B
2.238 NM_019738 Nupr1 Nuclear protein 1
2.235 NM_009663 Alox5ap Arachidonate 5-lipoxygenase
activating protein
2.228 XM_283054 Colec11 Collectin subfamily member 11
2.227 NM_020047 Tacstd2 Tumor-associated calcium signal
transducer 2
2.224 NM_018811 Abhd2 Abhydrolase domain containing 2
2.203 NM_021297 Tlr4 Toll-like receptor 4
2.202 NM_145403 Tmprss4 Transmembrane protease, serine 4
2.198 NM_011382 Six4 Sine oculis-related homeobox 4 homolog
2.186 NM_019738 Nupr1 Nuclear protein 1
2.166 NM_054095 Efcbp2 EF hand calcium binding protein 2
2.159 NM_009259 Spn Sialophorin
2.154 NM_134134 A630042L21Rik
2.153 NM_023755 Tcfcp2l1 Transcription factor CP2-like 1
2.127 NM_144533 Nmnat3 Nicotinamide nucleotide
adenylyltransferase 3
2.112 NM_181650 Prdm4 PR domain containing 4
2.11 NM_009657 Aldoc Aldolase 3, C isoform
2.067 NM_010008 Cyp2j6 Cytochrome P450, family 2,
subfamily j, polypeptide 6
2.066 NM_197999 2210023G05Rik
2.048 BF138688 BC064078
2.017 XM_129913 Dock10 Dedicator of cytokinesis 10
2.013 XM_286373 1810010H24Rik RIKEN cDNA 1810010H24 gene
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development and when it was induced only from E16.5 to E18.5.
This observationwas distinct from the effect of ELF5 misexpression on
lung morphogenesis, which was stage-dependent, suggesting that
ELF5 disrupts lung epithelial branching and differentiation by
affecting different target genes.
In addition to Elf5 (Ese2), the Epithelial Speciﬁc Ets family also
includes Ese1 (Elf3), Ese3 (Ehf) and Spdef (Pdef) (Feldman et al., 2003),
all of which are expressed in the lung (Kas et al., 2000; Lei et al., 2007;
Oettgen et al., 1999; Park et al., 2007; Silverman et al., 2002; Zhou et
al., 1998). We found that SFTPC/Elf5 lungs contained increased Ese3
and Spdef levels, suggesting the possibility that ELF5 may control their
expression. SPDEF, which is expressed in airway epithelial cells,
appears to regulate cell differentiation and gene expression, since
misexpression of SPDEF in the airway epithelium induced goblet cell
hyperplasia (Park et al., 2007). We saw no evidence of goblet cell
hyperplasia in the distal epithelial cysts of SFTPC/Elf5 lungs, indicating
that the inﬂuence of SPDEF on target gene expression and cell
phenotype may be regionally speciﬁc. ESE-3 is also expressed in the
airway epithelium, especially in serous and mucous glands, (Tugores
et al., 2001). Little is known about the function of ESE-3 in the lung,
other than that it is required for induction of the squamous
differentiation marker SPRR1B in human bronchial epithelial cells
(Reddy et al., 2003). In other tissues, however, ESE-3 functions as a
context-dependent transcriptional repressor that lies downstream of
MAPK signaling (Tugores et al., 2001), in cellular senescence (Fujikawa
et al., 2007), and as a tumor suppressor in prostate cancer (Cangemi et
al., 2008). Since ELF5 expression increases in proximal airway
epithelium late in gestation, and because ELF5 induced the proximal
airway epithelial genes Spdef and Ese3, we asked whether the high
levels of ELF5 seen in SFTPC/Elf5 lungs induced the distal epithelial
cells to adopt a proximal epithelial cell phenotype. We found,
however, that CCSP and FoxJ1, markers of Clara and ciliated cells,
respectively, were not induced in the cystic distal epithelium,
indicating that ELF5 by itself cannot induce fully differentiated airway
epithelial cells.
Fig. 7. Cystic regions of E16.5 SFTPC/Elf5 lungs were compared by microarray to spatially similar areas of SFTPC-rtTA control lungs to identify upregulated genes. qPCR for
expression of 6 of the genes identiﬁed–Spink5, Spink4, Scg3a1, Scgb3a2, Tff3 and p63–conﬁrms that all were induced or increased in SFTPC/Elf5 lungs (A; n=3; ⁎ = pb0.05;
⁎⁎ = pb0.0001; ⁎⁎⁎ = expression not detected in controls). IHC for p63 in SFTPC-rtTA and SFTPC/Elf5 lungs in E16.5 (DOX E0–E16.5) and E18.5 (DOX E16.5–E18.5) lungs
shows that p63 was absent in control lungs (B, D) but induced in double transgenic lungs (C, E). Insets in panels B and D show control staining for p63 in esophageal
epithelium in the same section. Examination of an E17.5 wild-type fetus (F) shows that Elf5 (G) and p63 (H) are endogenously co-expressed in the esophageal (es) and
tracheal (tr) epithelium. Scale bars: 100 μm.
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Although a primary role of FGF10 in lungmorphogenesis is to act as
an epithelial cell chemoattractant (Park et al., 1998), it has also been
proposed to maintain epithelial cells as undifferentiated progenitor
cells (Norgaard et al., 2003; Nyeng et al., 2007; Ramasamy et al., 2007).
Our data showing that ELF5 misexpression represses type II cell
maturation and the expression of Sftpc, Erm, and Napsa suggest that
Elf5, a target gene of FGF10 (Metzger et al., 2007), may act in this
process. If this is the case, the silencing of Elf5 in the distal epithelium
that normally occurs in late gestation would be required for normal
differentiation to proceed. In support of the concept that ELF5
maintains undifferentiated progenitors, we found that ELF5 over-
expression induced p63 and Aqp3, genes that normally mark
undifferentiated basal cells of the tracheobronchial epithelium(Avril-Delplanque et al., 2005; Daniely et al., 2004; Liu et al., 2007;
Rawlins and Hogan, 2006; Sato et al., 2004). Basal cells of pseudos-
tratiﬁed epithelia (e.g. tracheal epithelium) and stratiﬁed epithelium
(e.g. esophageal epithelia and epidermis) are a source of progenitor
cells in these tissues (Daniely et al., 2004; Yang et al., 1998). Basal cells
in the adult trachea and bronchi can repopulate the injured
epithelium and give rise to fully differentiated cell types, suggesting
they behave as stem cells (Hong et al., 2004a,b). The fact that we
observed many p63 positive cells in SFTPC/Elf5 lungs suggests the
possibility that the dilated cysts may represent a population of
progenitor cells. Some reports have suggested that p63 is important
for the maintenance of progenitor/stem cells, but this is not fully
resolved and is complicated by the existence of various p63 isoforms
that can perform distinct functions (Blanpain and Fuchs, 2007;
Koster et al., 2007, 2004, 2005; Senoo et al., 2007; Yang et al., 1999).
Fig. 8. E16.5 SFTPC/Elf5 lungs were compared to controls by qPCR for expression of other Ets transcription factors (n=5) Sftpc (n=5) and Napsa (n=3). Elf5was signiﬁcantly (pb0.005)
increased in SFTPC/Elf5 lungs, as were the Epithelial Speciﬁc Ets genes, Ese3 (pb0.005) and Spdef (pb0.05). The expression of Sftpc, Napsa, and Erm, however, were signiﬁcantly
(pb0.0001) reduced in SFTPC/Elf5 lungs. The expression of Pea3 and the Epithelial Speciﬁc Ets gene Ese1 did not change signiﬁcantly.
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but the fact that they express TTF1 indicates that they are in the
respiratory lineage (Zhou et al., 1996). Although our microarray data
showed that high expression of ELF5 repressed some genes that were
present in adult type II cells, it simultaneously induced others, such as
Sftpd, Spink5, and Scgb3a1. It should be noted, however, that these
genes are not restricted to type II cells, since they are also expressed in
proximal airway epithelium (Crouch et al., 1992; Reynolds et al., 2002;
Walden et al., 2002; Wong et al., 1996). These cells, however, are not
fully differentiated airway epithelial cells, since they lack markers for
type II, Clara, or ciliated cells.
Disruption of the normal program of epithelial differentiation by
high levels of ELF5 may activate new downstream targets that allow
the cells to adopt a different fate, as evidenced by our observation
that Spink4, Guca2a, Tff3 and Dcpp were induced in the cysts of
SFTPC/Elf5 lungs. These are genes that are normally expressed in the
intestine and not the lung parenchyma. A previous study has shown
that hyperactivation of β-catenin transcriptional activity directed to
lung epithelial progenitors produced dilated epithelial cysts and
suppressed type II cell differentiation (Okubo and Hogan, 2004).
Some of the cells in the cysts expressed Spink4, Guca2a, Tff3 and
Dcpp, and the authors concluded that these cells had been induced
to change fate by a process termed transdetermination. Although we
observed that these genes were induced in SFTPC/Elf5 lungs, our
microarrays showed no changes in Wnt-related gene expression.
Furthermore, Okubo et al. did not report a change in Elf5, indicating
that Elf5 is not downstream of WNT signaling. A more recent study
by Nyeng et al. showed that FGF10 misexpressed under control of
the Pdx1 promoter caused cystic dilation of the branching lung with
induced expression of Tff3 (Nyeng et al., 2008). The epithelial cells
in these lungs co-expressed markers associated with the early distal
lung epithelium (e.g. SP-C and TTF1), but did not show evidence of
transdetermination, leading the authors to conclude that excessive
FGF10 signaling arrested epithelial cell differentiation and main-
tained the cells as progenitors. This phenotype is similar, but not
identical, to that which we observed in SFTPC/Elf5 mice, which were
SP-C negative. Because we have previously shown that Elf5 is adownstream target of FGF10 (Metzger et al., 2007), we speculate
that some of the effects of FGF10 misexpression on maintaining
epithelial cells in a progenitor state may be due to increased
expression of ELF5.
In summary, we have used an inducible transgenic mousemodel to
show that high levels of ELF5 in the distal lung epithelium disrupt
normal lung morphogenesis and epithelial cell differentiation. Our
results suggest that ELF5 must be present at precise levels for the
proper speciﬁcation and subsequent differentiation of lung epithelial
cells. Our data also suggest that the role of ELF5 in lung epithelial cell
differentiation is complex, and may depend on other components in
the transcriptional networks regulating the differentiation of
individual lung epithelial cell types.
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